Skip to main content
SpringerLink
Log in

Findings from the MATRIX* study have shown that patients with overactive bladder (OAB) who are treated with oxybutinin transdermal system (TDS)

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Pizzi LT, Talati A, Gemmen E, Dahl NV, Bunz TJ, Sand PK.Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: results from the MATRIX study. PharmacoEconomics 27: 329-339, No. 4, 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Findings from the MATRIX* study have shown that patients with overactive bladder (OAB) who are treated with oxybutinin transdermal system (TDS). Pharmacoecon. Outcomes News 582, 8 (2009). https://doi.org/10.2165/00151234-200905820-00017

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905820-00017

Keywords

Search

Navigation